Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$259K Sell
5,123
-19,647
-79% -$967K ﹤0.01% 1172
2019
Q2
$1.19M Buy
+24,770
New +$1.15M 0.01% 722
2017
Q4
Sell
-30,160
Closed -$1.11M 1264
2017
Q3
$1.11M Buy
30,160
+23,067
+325% +$931K 0.01% 709
2017
Q2
$322K Buy
7,093
+601
+9% +$26.5K ﹤0.01% 1017
2017
Q1
$276K Sell
6,492
-3,422
-35% -$140K ﹤0.01% 1064
2016
Q4
$396K Buy
+9,914
New +$383K ﹤0.01% 1103
2014
Q2
Sell
-35,238
Closed -$757K 1530
2014
Q1
$757K Sell
35,238
-453
-1% -$9.77K ﹤0.01% 1108
2013
Q4
$796K Sell
35,691
-1,224
-3% -$27K ﹤0.01% 1043
2013
Q3
$761K Sell
36,915
-5,045
-12% -$107K ﹤0.01% 1033
2013
Q2
$808K Buy
+41,960
New +$877K ﹤0.01% 937

Other funds holding HOLX

Suntrust Banks's HOLX Position: Q3 2019 in Review

Suntrust Banks reduced its Hologic (HOLX) stake by 79% in Q3 2019, selling an estimated $967K and leaving 5,123 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Suntrust Banks first reported a position in HOLX in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.19M in Q2 2019. 493 funds tracked by Wall St. Rank hold HOLX as of Q3 2019.

  • Suntrust Banks held 5,123 shares of Hologic worth $259K as of Q3 2019.
  • Suntrust Banks sold 19,647 Hologic shares in Q3 2019, an estimated $967K.
  • Hologic made up ﹤0.01% of Suntrust Banks's portfolio in Q3 2019, its #1172 holding.
  • Suntrust Banks first reported a position in Hologic in Q2 2013 and has held it in 10 quarters since.
  • Suntrust Banks's Hologic position peaked at $1.19M in Q2 2019.
  • 493 funds tracked by Wall St. Rank held Hologic as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.